Showing results (161-170 of 187) with videos related to

Sort By:
Pageof 19
Lung Cancer (Amsterdam, Netherlands)|December 7, 2013
Clinical characteristics of non-small cell lung cancer patients who experienced acquired resistance during gefitinib treatmentHye-Ryoun Kim, Jae Chol Lee, Young-Chul Kim, et al.
Translational Lung Cancer Research|January 24, 2022
Real-world experience of afatinib as first-line therapy for advanced <i>EGFR</i> mutation-positive non-small cell lung cancer in KoreaSung Yong Lee, Chang-Min Choi, Yoon Soo Chang, et al.
Translational Lung Cancer Research|December 13, 2023
Real-world first-line afatinib for advanced <i>EGFR</i> mutation-positive non-small cell lung cancer in Korea: updated survival dataJuwhan Choi, Chang Min Choi, Yoon Soo Chang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 21, 2023
Korean Real-World Data on Patients With Unresectable Stage III NSCLC Treated With Durvalumab After Chemoradiotherapy: PACIFIC-KRCheol-Kyu Park, Hyung-Joo Oh, Young-Chul Kim, et al.
Lung Cancer (Amsterdam, Netherlands)|September 24, 2008
Lung cancer patients who are asymptomatic at diagnosis show favorable prognosis: a korean Lung Cancer Registry StudyKwang-Ho In, Yong-Soo Kwon, In-Jae Oh, et al.
Pageof 19